Skip to main content

and
  1. Article

    Open Access

    Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis

    Atopic dermatitis (AD) is a chronic relapsing condition with high disease burden and impact on health-related quality of life (HRQoL). Correlations between clinician- and patient-reported outcomes tend to be p...

    Hidehisa Saeki, Yoko Kataoka, Takafumi Etoh, Norito Katoh in Dermatology and Therapy (2024)

  2. Article

    Open Access

    Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study

    Insights into real-world treatment of atopic dermatitis (AD) are relevant to clinical decision making. The aim of this analysis was to characterize patients who receive dupilumab for AD in a real-world setting.

    Piergiacomo Calzavara-Pinton, Jarmila Čelakovská, Hilde Lapeere in Advances in Therapy (2023)

  3. Article

    Open Access

    Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment

    Previous drug survival studies of dupilumab in atopic dermatitis (AD) show that many patients continue treatment through 1 year, suggesting that patients experience clinically relevant benefits with long-term ...

    April Armstrong, Andrew Blauvelt, Eric L. Simpson in Dermatology and Therapy (2022)